Skip to main content
Caplight Logo









Yikon Genomics

Yikon Genomics

Private
ShanghaiHealthcare & Life Scienceshttps://yikongenomics.com/

Last Round

Series D

May 6, 2021

Total Funding Raised

$95.42M

Company Overview

Yikon Genomics is a biotechnology company that provides single-cell sequencing services and products for reproductive health and cancer diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Hardware + Subscription

AI Layer

Application

Keywords

preimplantation genetic testingPGTsingle-cell genomicsMALBAC technologyIVF genetic testingreproductive geneticsnext-generation sequencingNGSembryo screeningPGT-APGT-Mgenomics diagnosticsliquid biopsynon-invasive preimplantation genetic testingendometrial receptivity testERTbioinformatics softwaregenomics reagents

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Yikon Genomics Comparables

Compare Yikon Genomics with similar companies based on industry and business-model similarity.

Yikon Genomics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Basecare
83%
Progenesis
82%
Juno Genetics
80%

Yikon Genomics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DMay 6, 2021
StrategicOct 1, 2020
Series CNov 5, 2019
Series BSep 1, 2016
Series AAug 1, 2015

Yikon Genomics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 17, 2025

    Grew 17% QoQ, from 35 to 41 employees.

  • Sep 3, 2023

    Grew 36% QoQ, from 22 to 30 employees.

Yikon Genomics Filings

Explore SEC and related filing metadata, where available.

Yikon Genomics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Yikon Genomics's valuation, stock price, and market status.

Is Yikon Genomics a public or private company?

Yikon Genomics is a private company.

What is the current stock price of Yikon Genomics?

Yikon Genomics is a private company with no public stock price. No recent secondary market data is available.

How much is Yikon Genomics worth (valuation)?

Valuation information for Yikon Genomics is not publicly available.

Can I buy Yikon Genomics stock?

Yikon Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Yikon Genomics's last funding round?

Funding round information for Yikon Genomics is not publicly available.

Who are the main investors in Yikon Genomics?

Investor information for Yikon Genomics is not publicly disclosed.

Will Yikon Genomics IPO soon?

No public IPO plans have been announced for Yikon Genomics.

How can I track Yikon Genomics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Yikon Genomics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersShanghai
Employee Range56
Year Founded2012
Last FundingMay 6, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?